Metabolic dysfunction-associated steatotic liver disease may increase intrahepatic interferon gene signatures in patients with chronic hepatitis B

Accession: GSE288077
Source / host: GEO — NCBI GEO FTP
Disease relevance: MASLD / NAFLD / NASH (category: Transcriptomic, subtype: bulk RNA-seq)
Modality / assay: bulk-RNAseq
Platform: Expression profiling by high throughput sequencing, GPL34284;34290
Organism: human
Samples: 35
Size (indexed): 5.2 MB (5495931 bytes)
Downloaded bytes: 5.2 MB (5495931 bytes)
Access / raw: public / OPEN-raw

Download

Files

FileSizeSHA256
GSE288077_Human_FPKMs.csv.gz2.5 MBc7deab2fa37a2b33…
GSE288077_Mouse_FPKMs.csv.gz1.2 MB5284c6150f058ae8…
GSE288077_raw_counts_Human.txt.gz1020.6 KBd2d4266600201132…
GSE288077_raw_counts_Mouse.txt.gz537.5 KBe6d72357e211a36c…

Index note: 4 suppl file(s); GSE288077_raw_counts_Human.txt.gz

Crawled by masld-atlas-crawler v1.0 at 2026-08-02T17:01:47Z.

About this dataset

This Expression profiling by high throughput sequencing, GPL34284;34290 dataset provides single-cell gene expression from human liver samples, with disease state recorded as MASLD/NAFLD/NASH. It profiles about 35 cells or nuclei.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.